Ozempic: Dosing, Injection Sites, Tracking

Quick Reference

• What it is: Semaglutide, a GLP-1 receptor agonist
• What it treats: Type 2 diabetes (FDA-approved); also reduces cardiovascular risk in T2D patients
• How it's administered: Once-weekly subcutaneous injection via pre-filled pen
• Standard dosing range: 0.25 mg (initiation) to 2 mg (maintenance)
• Needle: 34-gauge, 4 mm (built into pen)

Ozempic is a once-weekly semaglutide pen manufactured by Novo Nordisk for type 2 diabetes management. It was FDA-approved in 2017 and has become one of the most widely prescribed GLP-1 receptor agonists in the world. If you're starting Ozempic or already on it, this page covers the practical details: how the drug works, how to dose it, where to inject, what side effects to expect, and how to track your treatment so you and your prescriber can make informed decisions.

What Ozempic Is

Ozempic is a brand name for semaglutide, a synthetic analog of the human GLP-1 hormone. It comes as a pre-filled, multi-dose pen in four dose configurations: 0.25 mg, 0.5 mg, 1 mg, and 2 mg per injection. Each pen contains multiple doses -- the exact number depends on the dose setting.

Ozempic is not insulin. It works through a completely different mechanism and is typically prescribed alongside other diabetes therapies, including metformin, SGLT2 inhibitors, and sometimes basal insulin.

The pen uses a 34-gauge, 4 mm needle that attaches before each injection. You dial your dose, inject subcutaneously, and hold for 6 seconds. The pen tracks remaining doses internally.

How It Works

Semaglutide mimics GLP-1, a hormone your gut releases after eating. Natural GLP-1 breaks down in minutes. Semaglutide has been structurally modified to resist degradation, giving it a half-life of approximately 7 days -- which is why one injection covers an entire week.

The drug acts through several parallel pathways:

• Insulin secretion: Stimulates the pancreas to release insulin when blood glucose is elevated. This is glucose-dependent, meaning it doesn't trigger insulin release when blood sugar is normal -- a significant safety advantage over older diabetes drugs like sulfonylureas.
• Glucagon suppression: Reduces glucagon output from the pancreas, which lowers the liver's glucose production.
• Gastric emptying: Slows the rate at which food leaves your stomach, blunting post-meal glucose spikes and contributing to a feeling of fullness.
• Appetite regulation: Acts on GLP-1 receptors in the hypothalamus to reduce hunger signaling.

These effects combine to lower HbA1c, reduce fasting and post-prandial blood glucose, and often produce meaningful weight loss as a secondary benefit.

Approved Uses

Ozempic is FDA-approved for two indications in adults:

1. Type 2 diabetes mellitus -- to improve glycemic control as an adjunct to diet and exercise.
2. Cardiovascular risk reduction -- to reduce the risk of major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in adults with type 2 diabetes and established cardiovascular disease.

Ozempic is not FDA-approved for weight management. That indication belongs to Wegovy, which uses the same semaglutide molecule at a higher dose with a different titration schedule. Prescribers sometimes use Ozempic off-label for weight loss, but insurance coverage for that use varies significantly.

For a deeper look at the semaglutide molecule across all its brand names, see our semaglutide guide.

Dosing

Ozempic uses a stepped titration schedule. You do not start at the maintenance dose.

The 0.25 mg starting dose is not therapeutic -- it exists to let your GI system adjust. Skipping it or rushing through it is the most common cause of unnecessary nausea and vomiting in the first month.

Your prescriber will decide whether to hold at 0.5 mg, move to 1 mg, or escalate to 2 mg based on your HbA1c response, tolerability, and overall treatment goals. Not everyone needs 2 mg. Many people achieve target glycemic control at 0.5 or 1 mg.

Dose timing: Inject on the same day each week, at any time of day, with or without food. If you need to change your injection day, you can do so as long as your last dose was at least 2 days (48 hours) prior.

Injection Sites and Technique

Ozempic is a subcutaneous (SubQ) injection. The pen's built-in 34-gauge, 4 mm needle makes injection straightforward -- this is one of the thinnest needles used in any injectable medication.

Approved injection sites

• Abdomen: At least 2 inches from the navel. This is the most popular site -- easy to reach, generally well-tolerated, and consistent absorption.
• Front of the thigh: Mid-thigh on the anterior surface. Some people find this slightly more sensitive than the abdomen.
• Back of the upper arm: Viable but harder to self-inject. Often used when someone else administers the injection.

Technique

1. Attach a new pen needle for each injection.
2. Prime the pen by dialing to the flow check symbol and pressing the dose button until a drop appears at the needle tip.
3. Dial to your prescribed dose.
4. Pinch the skin at your chosen site (no alcohol swab required per current guidelines, though many people prefer to swab).
5. Insert the needle at a 90-degree angle.
6. Press the dose button and hold for 6 seconds after the dose counter returns to zero.
7. Remove the needle and dispose of it in a sharps container.

Site rotation

Rotate your injection site each week. The simplest system: divide your abdomen into four quadrants (upper-left, upper-right, lower-left, lower-right) and cycle through them on a 4-week schedule. If you also use thigh and arm sites, incorporate those into the rotation.

Injecting the same spot repeatedly causes lipohypertrophy -- hardened tissue that impairs drug absorption. Our GLP-1 injection site rotation guide covers rotation systems in detail.

Side Effects to Track

Common (reported in >5% of trial participants)

• Nausea -- the most frequent side effect, reported by ~20% on the 1 mg dose. Typically peaks in the first 1-3 days after a dose increase and diminishes within a few weeks at each dose level.
• Diarrhea and constipation -- can alternate. Stay hydrated.
• Vomiting -- more common during dose escalation. If persistent, your prescriber may slow the titration.
• Abdominal pain -- usually mild to moderate.
• Decreased appetite -- expected pharmacological effect, not a side effect per se, but worth tracking.

Less common but clinically significant

• Injection site reactions -- redness, swelling, or itching. Usually resolves on its own.
• Gallbladder events -- gallstones and cholecystitis have been reported at higher rates, particularly with rapid weight loss.
• Pancreatitis -- rare but serious. Report sudden severe abdominal pain radiating to the back.
• Diabetic retinopathy complications -- reported in SUSTAIN-6, particularly in patients with pre-existing retinopathy who experienced rapid HbA1c improvement. Discuss with your ophthalmologist if applicable.

Boxed warning

Ozempic carries a boxed warning about thyroid C-cell tumors based on rodent studies. This has not been confirmed in humans. However, Ozempic is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

What to Monitor

Bloodwork

• HbA1c: Checked every 3 months until stable, then at least every 6 months. This is the primary marker of glycemic control.
• Fasting glucose: Useful for interim monitoring between HbA1c checks.
• Kidney function (eGFR, BUN, creatinine): GLP-1 agonists can affect hydration status; kidney function should be monitored, especially if you experience persistent GI symptoms.
• Lipid panel: Semaglutide has shown modest improvements in triglycerides and LDL in some studies.
• Liver enzymes: Baseline and periodic monitoring recommended.
• Amylase/lipase: If pancreatitis is suspected.

Self-monitoring

• Blood glucose: Frequency depends on your overall regimen. If you're on sulfonylureas or insulin alongside Ozempic, monitor more frequently for hypoglycemia. Ozempic alone rarely causes hypoglycemia.
• Weight: Weekly weigh-ins on the same day, same conditions. Weight loss is a common secondary effect even though Ozempic isn't indicated for it.
• Blood pressure: Metabolic improvements often reduce BP. Track it so your prescriber can adjust antihypertensives if needed.
• GI symptoms: Log severity, timing relative to injection, and duration. This data is critical during titration.

Comparison to Alternatives

Ozempic's primary advantages are its strong cardiovascular evidence, once-weekly dosing, and extensive real-world data. Mounjaro (tirzepatide) may produce greater HbA1c and weight reductions based on head-to-head data in SURPASS-2, but it's a newer drug with less long-term safety data. Daily injectables like Victoza require more frequent dosing, which affects adherence.

Tracking Your Treatment

Weekly injectables are easy to lose track of. You inject once, feel fine, and then seven days later you're trying to remember -- did I inject on Tuesday or Wednesday? Which side did I use?

This matters more than it sounds. Inconsistent dosing undermines glycemic control. In the SUSTAIN trials, adherence was tightly controlled, which is partly why the results were so strong. Real-world adherence to GLP-1 agonists is significantly lower than in trials, and outcomes suffer accordingly.

What to log every week:

• Date and time of injection
• Dose (especially during titration -- track every change)
• Injection site and side (e.g., "abdomen, lower-left quadrant")
• Pen lot number (useful if you suspect a pen malfunction or recall)
• Side effects within 72 hours, with severity and duration
• Fasting glucose if you're tracking it
• Next scheduled dose date

Done Dose is built for exactly this workflow. Log your injection in seconds, get reminders on your injection day, and track site rotation automatically so you never have to think about where you injected last week. When it's time to see your prescriber, your entire treatment history is in one place.

Frequently Asked Questions

What is the starting dose for Ozempic?

Ozempic starts at 0.25 mg once weekly for the first 4 weeks. This is a tolerability dose, not a therapeutic dose. After 4 weeks, your prescriber will typically increase to 0.5 mg weekly, with further increases to 1 mg or 2 mg based on your glycemic response and tolerability.

Where do you inject Ozempic?

Ozempic is injected subcutaneously into the abdomen (at least 2 inches from the navel), the front of the thigh, or the back of the upper arm. Rotate your injection site each week to prevent lipohypertrophy and ensure consistent absorption.

What happens if you miss an Ozempic dose?

If your next scheduled dose is more than 2 days away, take the missed dose as soon as you remember. If it's 2 days or fewer until your next dose, skip the missed one and resume your regular schedule. Never take two doses to make up for a missed one.

Is Ozempic the same as Wegovy?

Both contain semaglutide and use the same delivery mechanism, but they are FDA-approved for different indications. Ozempic is approved for type 2 diabetes (max dose 2 mg), while Wegovy is approved for chronic weight management (max dose 2.4 mg). They also have different titration schedules.

How long does it take for Ozempic to lower blood sugar?

Most people see measurable improvements in fasting blood glucose within the first few weeks. However, reaching steady-state drug levels takes about 4-5 weeks at any given dose, and the full titration to maintenance dose takes 8 weeks or more. HbA1c changes are typically assessed after 3 months on a stable dose.

Sources

1. Novo Nordisk. "Ozempic (semaglutide) Prescribing Information." novo-pi.com/ozempic.pdf
2. Marso SP, et al. "Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes." The New England Journal of Medicine, 2016. DOI: 10.1056/NEJMoa1607141
3. Rubino DM, et al. "Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss." JAMA, 2022. DOI: 10.1001/jama.2021.18813
4. U.S. Food and Drug Administration. "FDA Approves New Dosage Strength of Ozempic (2 mg)." fda.gov
5. Frid AH, et al. "Injection Technique and Pen Needle Technology: Best Practice Guidelines." World Journal of Diabetes, 2021. DOI: 10.4239/wjd.v12.i6.740

Done Dose helps you track weekly Ozempic injections, rotate sites, log side effects, and share your treatment history with your prescriber. Download Done Dose to stay on top of your protocol.